Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I W Dimery

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neckJ Paredes, W K Hong, T B Felder, et al.
Head & Neck|January 1, 1994
Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experienceM H Shirinian, R S Weber, S M Lippman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancerM H Huber, S M Lippman, S E Benner, et al.
Investigational New Drugs|February 1, 1993
Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancerN Voravud, S M Lippman, R S Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancerR F DeVore, D H Johnson, J Crawford, et al.
Cancer|September 1, 1991
Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancerJ S Lee, H I Libshitz, F V Fossella, et al.
Journal of the National Cancer Institute|July 1, 1992
Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancerJ S Lee, H I Libshitz, F V Fossella, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neckJ Paredes, W K Hong, T B Felder, et al.
Head & Neck|January 1, 1994
Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experienceM H Shirinian, R S Weber, S M Lippman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancerM H Huber, S M Lippman, S E Benner, et al.
Investigational New Drugs|February 1, 1993
Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancerN Voravud, S M Lippman, R S Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancerR F DeVore, D H Johnson, J Crawford, et al.
Cancer|September 1, 1991
Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancerJ S Lee, H I Libshitz, F V Fossella, et al.
Journal of the National Cancer Institute|July 1, 1992
Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancerJ S Lee, H I Libshitz, F V Fossella, et al.
Pageof 4